v3.20.2
Condensed Consolidated Balance Sheets (Unaudited) - USD ($)
Sep. 30, 2020
Dec. 31, 2019
ASSETS    
Cash and cash equivalents $ 34,364,560 $ 16,350,237
Restricted cash 182,892 174,950
Short-term investments 2,674,770 11,984,157
Trade receivables 6,118 35
Inventories, net 200,706 338,465
Prepaid research and development expenses 76,182 34,831
Security deposit 20,000 20,000
Other prepaid expenses and current assets 1,340,239 446,415
Total current assets 38,865,467 29,349,090
Property and equipment, net 115,092 122,130
Operating lease right-of-use assets 1,041,991 4,690
TOTAL ASSETS 40,022,550 29,475,910
LIABILITIES AND STOCKHOLDERS’ EQUITY    
Accounts payable 1,986,100 1,024,280
Accrued expenses 2,516,841 4,798,475
Operating lease liabilities, short-term 98,072 2,011
Deferred revenue   2,206
Total current liabilities 4,601,013 5,826,972
Operating lease liabilities, net of current portion 952,318 2,678
TOTAL LIABILITIES 5,553,331 5,829,650
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS’ EQUITY    
Preferred stock - $0.001 par value: 2,000,000 shares authorized; 241,623 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 242 242
Common stock - $0.001 par value: 160,000,000 shares authorized; 31,348,171 and 25,665,350 shares issued and outstanding at September 30, 2020 and December 31, 2019, respectively 31,348 25,665
Accumulated other comprehensive income 99,659 97,257
Additional paid-in capital 245,699,880 218,944,268
Accumulated deficit (211,361,910) (195,421,172)
TOTAL STOCKHOLDERS’ EQUITY 34,469,219 23,646,260
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 40,022,550 $ 29,475,910